Evaluating the Prognostic Significance of the Coefficient of Variation in Metabolic Heterogeneity from Baseline 18F-FDG PET/CT in Newly Diagnosed Diffuse Large B-Cell Lymphoma - Poll - MDSpire

Evaluating the Prognostic Significance of the Coefficient of Variation in Metabolic Heterogeneity from Baseline 18F-FDG PET/CT in Newly Diagnosed Diffuse Large B-Cell Lymphoma

  • By

  • Siqi Hu

  • Zijie Shen

  • Ting Yang

  • Yujie Xie

  • Qiong Zou

  • Ju Jiao

  • Muhua Cheng

  • Yong Zhang

  • February 23, 2026

  • 0 min

Share

Original Source(s)

Evaluating the Prognostic Significance of the Coefficient of Variation in Metabolic Heterogeneity from Baseline 18F-FDG PET/CT in Newly Diagnosed Diffuse Large B-Cell Lymphoma

  • by Siqi Hu, Zijie Shen, Ting Yang, Yujie Xie, Qiong Zou, Ju Jiao, Muhua Cheng, Yong Zhang

  • February 23, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026